Article
Sensei Biotherapeutics Acquires Faeth Therapeutics In Stock-To-Stock Transaction
The acquisition of Faeth was structured as a stock-for-stock transaction pursuant to which all of Faeth's outstanding equity interests were exchanged based on a fixed exchange ratio for a combination of 252,210 shares of Sensei common stock and approximately 10,604 shares of Series B non-voting convertible preferred stock (representing 10,604,490 shares on an as-converted-to-common basis).
Comments
- No comments yet. Be the first to comment!